Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection
This study demonstrates that performing sentinel node biopsy alone is feasible in patients with clinical node stage 2-3 after neoadjuvant chemotherapy. The findings suggest the potential for de-escalation of axillary management in these patients, which could be further explored in follow-up studies.
Authors
- Sae Byul Lee (ORCID: https://orcid.org/0000-0002-3370-6937)
- Eunju Shin
- Byung Ho Son (ORCID: https://orcid.org/0000-0002-6757-0388)
- Tae-Kyung Yoo
- Il Yong Chung (ORCID: https://orcid.org/0000-0001-5271-8530)
- Hee Jeong Kim (ORCID: https://orcid.org/0000-0002-4509-953X)
- Jisun Kim (ORCID: https://orcid.org/0000-0002-4884-6107)
- Jong Won Lee (ORCID: https://orcid.org/0000-0002-2203-3634)
- Beom Seok Ko (ORCID: https://orcid.org/0000-0001-7831-7874)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-20
- DOI
- https://doi.org/10.3389/fonc.2025.1563586
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81